IOL Chemicals and Pharmaceuticals Limited — Updates, 11-11-2025: Press Release
11-11-2025 | 06:09 pm
11-11-2025 | 06:09 pm
IOL Chemicals & Pharma reported strong Q2 results: revenue up 7.9% to ₹567.5 Cr, EBITDA surged 33.3% to ₹64 Cr, and PAT jumped 56.7% to ₹30 Cr. Margin expansion indicates efficiency. The company secured EU market access for Pantoprazole and expanded globally via IOL Pharmaxis UK.
No comments yet. Be the first to comment!
All announcements from IOL Chemicals and Pharmaceuticals Limited
